Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carmelo Nucera, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Carmelo Nucera and Matthew Nehs.
Connection Strength

0.565
  1. Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. Endocrinology. 2012 Feb; 153(2):985-94.
    View in: PubMed
    Score: 0.122
  2. Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist. 2011; 16(3):296-309.
    View in: PubMed
    Score: 0.115
  3. Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer. Surgery. 2010 Dec; 148(6):1154-62; discussion 1162.
    View in: PubMed
    Score: 0.113
  4. B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A. 2010 Jun 08; 107(23):10649-54.
    View in: PubMed
    Score: 0.109
  5. A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid. 2009 Oct; 19(10):1077-84.
    View in: PubMed
    Score: 0.105
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.